neuroleptic drug used in Tourette syndrome patients to suppress the occurrence of motor and vocal tics via a mechanism that inhibits dopamine signaling.  Presently there is a clinical trial (clinicaltrials.gov number  NCT03272503 ) which is ongoing to study the effects of pimozide in ALS.